KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 92 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,815,000 | -25.7% | 500,000 | -30.6% | 1.57% | +1.0% |
| Q2 2023 | $6,480,000 | -10.7% | 720,000 | -22.0% | 1.55% | -28.7% |
| Q1 2023 | $7,256,352 | +16.3% | 923,200 | 0.0% | 2.17% | +0.1% |
| Q4 2022 | $6,240,832 | -30.1% | 923,200 | +96.3% | 2.17% | +86.1% |
| Q4 2020 | $8,929,000 | +52.3% | 470,203 | 0.0% | 1.17% | +1.7% |
| Q3 2020 | $5,863,000 | +5.0% | 470,203 | +1.9% | 1.15% | +1.7% |
| Q2 2020 | $5,584,000 | +224.5% | 461,500 | +105.1% | 1.13% | +147.4% |
| Q1 2020 | $1,721,000 | – | 225,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |